comparemela.com

Latest Breaking News On - Single center study - Page 1 : comparemela.com

Delcath Systems Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

NEW YORK, March 27, 2023 /PRNewswire/ Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business. | March 27, 2023

United statesBen shamsianJohnr sylvesterGerard michelSerrado capitalInternational tollDrug administrationPrnewswire delcath systems incStonepine capital managementDelcath systems incCompany venture opportunity fundSingle center studyDelcath systemsHepatic delivery systemPrescription drug user fee actVivo capital

Delcath Systems, Inc : Delcath Systems Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

NEW YORK, March 27, 2023 /PRNewswire/ Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported

United statesGerard michelBen shamsianJohnr sylvesterPrnewswire delcath systems incDrug administrationSingle center studyStonepine capital managementCompany venture opportunity fundDelcath systems incSerrado capitalInternational tollDelcath systemsHepatic delivery systemPrescription drug user fee actVivo capital

CareDx Focuses on Innovation in Transplant at ASN Kidney

Two AlloSure abstracts will be featured at ASN, and CareDx will showcase innovations in transplantation at a virtual event on November 5.

United statesSouth san franciscoTitte srinivasSasha kingRobert montgomeryEnver akalinCian cooneyKalathilk sureshkumarEledon pharmaceuticalsAllegheny health networkMontefiore medical centerDigital developmentAmerican society of nephrologyCenter studyCaredx incYork university langone transplant institute

vimarsana © 2020. All Rights Reserved.